Literature DB >> 18207453

Prevalence of 'poor sleep' among patients with multiple sclerosis: an independent predictor of mental and physical status.

G Merlino1, L Fratticci, C Lenchig, M Valente, D Cargnelutti, M Picello, A Serafini, P Dolso, G L Gigli.   

Abstract

BACKGROUND: Patients with multiple sclerosis (MS) report sleep disturbances more frequently than the general population. Besides specific sleep disturbances, many other conditions could impair nocturnal rest in this population. In addition, information regarding the role of disrupted sleep on quality of life (QoL) in MS patients is lacking. This study was performed to bridge this gap.
METHODS: A total of 120 patients with MS were enrolled into the study. Demographic, socioeconomic and clinical characteristics (clinical course and duration of MS, EDSS score, therapeutic information, presence of pain, presence of sexual and/or bladder dysfunction, localization of demyelinating plaques, and presence of anxiety and depression) were collected. The Pittsburgh Sleep Quality Index (PSQI), the Charlson Comorbidity Index (CCI) and the Italian version of the 36-item Short Form (SF-36) were used to assess quality of sleep, comorbidity and QoL, respectively.
RESULTS: Nearly half (47.5%) of MS patients were classified as "poor sleepers," having significantly higher EDSS (3.1+/-1.4 vs. 2.3+/-1.4, p=0.009) and CCI scores (0.19+/-0.4 vs. 0.03+/-0.2, p=0.009) than "good sleepers." In addition, pain due to MS was more common among "poor sleepers" (33.3% vs. 17.7%, p=0.05). Scores for each domain of the SF-36, and the mental component summary (MCS) and physical component summary (PCS) scores were significantly lower in poor sleepers than in good sleepers (p<0.001 for each score). Of the different variables associated with MCS, the only independent predictors of mental status were: presence of sexual and/or bladder dysfunction and global PSQI score. The independent predictors for physical status (PCS) were age, EDSS score and global PSQI score.
CONCLUSIONS: Poor sleep is common in patients with MS, representing an independent predictor of QoL. Patients with MS who are poor sleepers should receive immediate assessment and treatment, bearing in mind that, in addition to specific sleep disturbances, other clinical conditions (both related and unrelated to MS) can disrupt nocturnal sleep.

Entities:  

Mesh:

Year:  2008        PMID: 18207453     DOI: 10.1016/j.sleep.2007.11.004

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  55 in total

Review 1.  Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment.

Authors:  Tiffany J Braley; Ronald D Chervin
Journal:  Sleep       Date:  2010-08       Impact factor: 5.849

2.  Impaired sleep quality and restless legs syndrome in idiopathic focal dystonia: a controlled study.

Authors:  Sebastian Paus; Jennifer Gross; Martina Moll-Müller; Frank Hentschel; Annika Spottke; Bettina Wabbels; Thomas Klockgether; Michael Abele
Journal:  J Neurol       Date:  2011-04-16       Impact factor: 4.849

3.  Sleep disorders in patients with multiple sclerosis in China.

Authors:  Shengli Ma; Xue Rui; Peiyi Qi; Gangqiong Liu; Jing Yang
Journal:  Sleep Breath       Date:  2016-10-11       Impact factor: 2.816

Review 4.  Quality of life in multiple sclerosis: determinants, measurement, and use in clinical practice.

Authors:  Deborah M Miller; Rebecca Allen
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

5.  Central sleep apnea in multiple sclerosis: a pilot study.

Authors:  Michael Lin; Arun V Krishnan; Danny J Eckert
Journal:  Sleep Breath       Date:  2016-12-14       Impact factor: 2.816

6.  A Cross-Sectional Study of the Impact of Spasticity on Daily Activities in Multiple Sclerosis.

Authors:  Francois Bethoux; Ruth Ann Marrie
Journal:  Patient       Date:  2016-12       Impact factor: 3.883

Review 7.  Sleep Abnormalities in Multiple Sclerosis.

Authors:  Giorgos K Sakkas; Christoforos D Giannaki; Christina Karatzaferi; Mauro Manconi
Journal:  Curr Treat Options Neurol       Date:  2019-01-31       Impact factor: 3.598

8.  Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.

Authors:  Montserrat González-Platas; Javier González-Platas; Moises Bermúdez-Hernández; Maria Yaiza Pérez-Martín; Cristina Croissier-Elías; Pedro Javier Pérez-Lorensu
Journal:  J Clin Sleep Med       Date:  2016-06-15       Impact factor: 4.062

9.  Beyond fatigue: Assessing variables associated with sleep problems and use of sleep medications in multiple sclerosis.

Authors:  Alyssa M Bamer; Kurt L Johnson; Dagmar A Amtmann; George H Kraft
Journal:  Clin Epidemiol       Date:  2010-05-01       Impact factor: 4.790

Review 10.  Sleep Disorders in Multiple Sclerosis.

Authors:  Tiffany J Braley; Eilis Ann Boudreau
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.